Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type

Interventional

Phase

Not applicable

Age range

18 years - Not specified

Sex eligible

All sexes

Healthy volunteers

Accepted

Participants

1319 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

The purpose of this study is to determine the most effective family-centered intervention (FCI) for weight loss and obesity prevention in Hispanic families. FCI is a type of program that involves family (such as parents and caregivers) supporting their children to promote healthy habits.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

Phase 1

• Age \>= 18 years (per self-report)
• Self-identifies as Hispanic/Latino (per self-report)
• Seeking, or has used, services at the VDS or MHU (per self-report)
• Is the parent or primary caregiver for at least one child aged 8-12 living in their household (per self-report)
• Screens as obese (BMI \> 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2) (per height and weight measurement in person or per self-report)
• Owns a cell phone capable of receiving text messages (per self-report)
• Owns an internet connected device (e.g. cell phone, tablet, etc.) capable of conducting videoconference calls (per self-report)
• Agrees to be audio-recorded (per self-report)

Phase 2 (parent participants)

• Age \>= 18 years (per self-report)
• Self-identifies as Hispanic/Latino (per self-report)
• Seeking, or has used, services at the VDS or MHU (per self-report)
• Is the parent or primary caregiver for at least one child aged 8-12 living in their household (per self-report)
• Screens as obese (BMI \> 30 kg/m2) or overweight (BMI of 25 - 29.9 kg/m2) (per height and weight measurement in person or remotely)
• Owns a cell phone capable of receiving text messages (per self-report)
• Owns an internet connected device (e.g. cell phone, tablet, etc.) capable of conducting videoconference calls (per self-report)
• Agrees to be audio-recorded (per self-report)

Phase 2 (child participants)

• Age 8-12 years (per parent self-report)
• Has a parent or primary caregiver who is eligible and participating in Phase 2 (per parent self-report)

Exclusion Criteria:

Phase 1

• Is pregnant or might be pregnant (per self-report)
• Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with hypertension and diabetes mellitus may still participate) that may affect diet and study participation (per self-report)
• Has dietary restrictions, i.e. liquid diet, that may affect diet and study participation (per self-report)
• Has a household member who has already participated or agreed to participate in this study program (per self-report)
• Prior participation in one of our preliminary studies, e.g., COMIDA, SANOS, Family COMIDA (per self-report) and any related focus groups
• Works for or with the VDS or MHU (per self-report)
• Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per study team)

Phase 2 (parent participant)

• Is pregnant or might be pregnant (per self-report)
• For women, is lactating (per self-report)
• Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with hypertension and diabetes mellitus may still participate) that may affect diet and study participation (per self-report)
• Has dietary restrictions, i.e., liquid diet, that may affect diet and study participation (per self-report)
• Has physical activity restrictions, i.e., handicapped or mobility issues, that may affect physical activity participation (increasing step counts; per self-report)
• Has a household member who has already participated or agreed to participate in this study program (per self-report)
• Prior participation in one of our preliminary studies, e.g., COMIDA, SANOS, Family COMIDA (per self-report) and any related focus groups
• Works for or with the VDS or MHU (per self-report)
• Presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per study team)
• Has been prescribed Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity (or other GLP 1 receptor agonist), or any other drug to treat obesity (per self-report) or (if previously prescribed) 7 weeks have not passed since the last dose was taken.
• Has undergone weight loss/bariatric surgery (RYBG, gastric banding, sleeve gastrectomy, balloon, etc.) or is planning to undergo such surgery in the next 12 months (per self-report)

Phase 2 (child participant)

• Has dietary restrictions, i.e., liquid diet, that may affect diet and study participation (per parent self-report)
• Has physical activity restrictions, i.e., handicapped or mobility issues, that may affect physical activity participation (per parent self-report)
• Has an eating disorder (per parent self-report)
• Is underweight (per parent self-report)

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment

Random assignment

Masking

No masking

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Study team and timeline

Lead sponsor

Memorial Sloan Kettering Cancer Center

Study start

Aug 26, 2025 Actual

Primary completion

Jul 31, 2029 Estimated

Study completion

Jul 31, 2029 Estimated

First posted

Aug 28, 2025 Actual

Last updated

Nov 10, 2026 Actual

Official study contacts